288 related articles for article (PubMed ID: 25339771)
1. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
2. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity.
Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J
Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
[TBL] [Abstract][Full Text] [Related]
4. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148.
Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D
Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794
[TBL] [Abstract][Full Text] [Related]
6. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.
He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J
J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
9. Role of RNA Domain Structure and Orientation in the Coxsackievirus B3 Virulence Phenotype.
Phillips L; Tapprich WE
J Virol; 2023 May; 97(5):e0044823. PubMed ID: 37074194
[TBL] [Abstract][Full Text] [Related]
10. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region.
Wu Y; Yue Y; Xiong S
Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-324-3p Plays A Protective Role Against Coxsackievirus B3-Induced Viral Myocarditis.
Liu T; Tong J; Shao C; Qu J; Wang H; Shi Y; Lin Y; Liu Y; Shao S; Shen H
Virol Sin; 2021 Dec; 36(6):1585-1599. PubMed ID: 34632544
[TBL] [Abstract][Full Text] [Related]
12. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation.
Xie W; Wang L; Dai Q; Yu H; He X; Xiong J; Sheng H; Zhang D; Xin R; Qi Y; Hu F; Guo S; Zhang K
J Mol Cell Cardiol; 2015 Aug; 85():155-67. PubMed ID: 26055448
[TBL] [Abstract][Full Text] [Related]
14. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
15. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
16. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
17. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.
Tong L; Lin L; Wu S; Guo Z; Wang T; Qin Y; Wang R; Zhong X; Wu X; Wang Y; Luan T; Wang Q; Li Y; Chen X; Zhang F; Zhao W; Zhong Z
Nucleic Acids Res; 2013 Apr; 41(6):3760-71. PubMed ID: 23389951
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA MEG3/miRNA-21/P38MAPK axis inhibits coxsackievirus 3 replication in acute viral myocarditis.
He F; Liu Z; Feng M; Xiao Z; Yi X; Wu J; Liu Z; Wang G; Li L; Yao H
Virus Res; 2024 Jan; 339():199250. PubMed ID: 37865350
[TBL] [Abstract][Full Text] [Related]
19. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
Wang Y; Pfeiffer JK
mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
[TBL] [Abstract][Full Text] [Related]
20. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]